2016 ESC Annual Meeting in Review: NOACs and NVAF: Real-World Data, Guidelines, and More

Introduction

Principles of AF Management

2016 ESC Guidelines for Diagnosis and Management of AF: Key Recommendations

2016 ESC Guidelines for Diagnosis and Management of AF: Key Recommendations (cont)

2016 ESC Guidelines for Diagnosis and Management of AF: Key Recommendations (cont)

2016 ESC Guidelines for Diagnosis and Management of AF: Key Recommendations (cont)

Real-World Data: An Important Source of Evidence

Real-World Data: NOACs

Drug Adherence and Persistence Results

Real-World Data: NOACS (cont)

Risk of Bleeding Among Elderly Patients on NOACs

Real-World Data: NOACs (cont)

Persistence of NOACs by Cohort Among NOAC-Naive Patients

Real-World Data: NOACs (cont)

Propensity Score-Matched Adjusted Incidence Rates of Major Bleeding Propensity Score-Matched Adjusted Incidence Rates of Major Bleeding* and HRs for Anticoagulant Initiation

Real-World Data: NOACs (cont)

Real-World Data: NOACs (cont)

ENSURE-AF: Edoxaban for Cardioversion of AF

Ensure-AF: Primary Efficacy Endpoint Results

Stroke Prevention in AF: Some Important Considerations

Things to Consider When Starting/Choosing a NOAC . . . Think ABCDE

Summary and Conclusions

Abbreviations

Abbreviations